Secondary Acquired Cholesteatoma: Presentation and Tympanoplasty Outcomes.

Published

Journal Article

OBJECTIVE: Comparing the clinical features and surgical outcomes of patients undergoing tympanoplasty for secondary acquired cholesteatoma (SAC) versus non-complicated tympanic membrane perforation (TMP). STUDY DESIGN: Retrospective patient review. SETTING: Tertiary-care, academic center. PATIENTS: All 41 patients with diagnosis of SAC confirmed at surgery between January 1, 2007 and June 30, 2014, and an age-matched cohort consisting of patients with TMP. INTERVENTION(S): Tympanoplasty using either medial or lateral graft techniques. MAIN OUTCOME MEASURE(S): Resolution of perforation, SAC, and symptoms. RESULTS: Comparison between the two cohorts failed to reveal significant differences in otologic symptomology, or presentation. There was no significant difference in the resolution of SAC (pā€Š=ā€Š0.7) between the medial and lateral tympanoplasty techniques. Both techniques also had similar rates of success in the TMP cohort. The medial graft technique was significantly (pā€Š=ā€Š0.008) more likely to result in a successfully repaired tympanic membrane in the TMP cohort compared with the SAC cohort. The Lateral graft technique demonstrated no significant difference in the likelihood of TMP and SAC resolution. CONCLUSION: The presentation of SAC is similar to that of TMP despite being a separate clinical entity. A clinician's ability to distinguish the two is important to mitigate the destructive potential of untreated SAC and correctly council patients on tympanoplasty success rates. This study was unable to demonstrate a significant difference in disease control between the medial and lateral tympanoplasty techniques, although potential advantages of each technique are discussed.

Full Text

Duke Authors

Cited Authors

  • Clark, JH; Feng, A; Harun, A; Brown, G; Francis, HW

Published Date

  • August 2016

Published In

Volume / Issue

  • 37 / 7

Start / End Page

  • 902 - 907

PubMed ID

  • 27273390

Pubmed Central ID

  • 27273390

Electronic International Standard Serial Number (EISSN)

  • 1537-4505

Digital Object Identifier (DOI)

  • 10.1097/MAO.0000000000001100

Language

  • eng

Conference Location

  • United States